Diagnostic value of soluble biomarkers for parapneumonic pleural effusion

References

• Chalmers JD, Singanayagam A, Murray MP, et al. Risk factors for complicated parapneumonic effusion and empyema on presentation to hospital with community-acquired pneumonia. Thorax. 2009;64(7):592–597.
   PubMed Web of Science ®Google Scholar
• Falguera M, Carratala J, Bielsa S, et al. Predictive factors, microbiology and outcome of patients with parapneumonic effusion. Eur Respir J. 2011;38(5):1173–1179.
   PubMed Web of Science ®Google Scholar
• Reissig A, Copetti R, Mathis G, et al. Lung ultrasound in the diagnosis and follow-up of community-acquired pneumonia: a prospective, multicenter, diagnostic accuracy study. Chest. 2012;142(4):965–972.
   PubMed Web of Science ®Google Scholar
• Han X, Chen L, Li H, CAP-China Network, et al. Prognostic factors for cardiovascular events in elderly patients with community acquired pneumonia: results from the CAP-China network. Clin Interv Aging. 2022;17:603–614.
   PubMed Web of Science ®Google Scholar
• Dean NC, Griffith PP, Sorensen JS, et al. Pleural effusions at first ED encounter predict worse clinical outcomes in patients with pneumonia. Chest. 2016;149(6):1509–1515.
   PubMed Web of Science ®Google Scholar
• Mortensen EM, Kapoor WN, Chang CC, et al. Assessment of mortality after long-term follow-up of patients with community-acquired pneumonia. Clin Infect Dis. 2003;37(12):1617–1624.
   PubMed Web of Science ®Google Scholar
• Cilloniz C, Ewig S, Polverino E, et al. Pulmonary complications of pneumococcal community-acquired pneumonia: incidence, predictors, and outcomes. Clin Microbiol Infect. 2012;18(11):1134–1142.
   PubMed Web of Science ®Google Scholar
• Addala DN, Bedawi EO, Rahman NM. Parapneumonic effusion and empyema. Clin Chest Med. 2021;42(4):637–647.
   PubMed Web of Science ®Google Scholar
• Roy B, Shak HJ, Lee YCG. Pleural fluid investigations for pleural infections. J Lab Precis Med. 2021;6:12–12.
   Google Scholar
• Sahn SA. Diagnosis and management of parapneumonic effusions and empyema. Clin Infect Dis. 2007;45(11):1480–1486.
   PubMed Web of Science ®Google Scholar
• Davies HE, Davies RJ, Davies CW, BTS Pleural Disease Guideline Group Management of pleural infection in adults: british thoracic society pleural disease guideline 2010. Thorax. 2010;65(Suppl 2):ii41–ii53.
   PubMedGoogle Scholar
• Sundaralingam A, Banka R, Rahman NM. Management of pleural infection. Pulm Ther. 2021;7(1):59–74.
   PubMedGoogle Scholar
• Porcel JM. Distinguishing complicated from uncomplicated parapneumonic effusions. Curr Opin Pulm Med. 2015;21(4):346–351.
   PubMed Web of Science ®Google Scholar
• Porcel JM. Pleural fluid tests to identify complicated parapneumonic effusions. Curr Opin Pulm Med. 2010;16(4):357–361.
   PubMed Web of Science ®Google Scholar
• Porcel JM, Esquerda A, Vives M, et al. Etiology of pleural effusions: analysis of more than 3,000 consecutive thoracenteses. Arch Bronconeumol. 2014;50(5):161–165.
   PubMed Web of Science ®Google Scholar
• Tian P, Qiu R, Wang M, et al. Prevalence, causes, and health care burden of pleural effusions among hospitalized adults in China. JAMA Netw Open. 2021;4(8):e2120306.
   PubMed Web of Science ®Google Scholar
• Maskell NA, Batt S, Hedley EL, et al. The bacteriology of pleural infection by genetic and standard methods and its mortality significance. Am J Respir Crit Care Med. 2006;174(7):817–823.
   PubMed Web of Science ®Google Scholar
• Marks DJ, Fisk MD, Koo CY, et al. Thoracic empyema: a 12-year study from a UK tertiary cardiothoracic referral Centre. PLOS One. 2012;7(1):e30074.
   PubMed Web of Science ®Google Scholar
• Wang XJ, Yang Y, Wang Z, et al. Efficacy and safety of diagnostic thoracoscopy in undiagnosed pleural effusions. Respiration. 2015;90(3):251–255.
   PubMed Web of Science ®Google Scholar
• Gordon CE, Feller-Kopman D, Balk EM, et al. Pneumothorax following thoracentesis: a systematic review and meta-analysis. Arch Intern Med. 2010;170(4):332–339.
   PubMedGoogle Scholar
• Ault MJ, Rosen BT, Scher J, et al. Thoracentesis outcomes: a 12-year experience. Thorax. 2015;70(2):127–132.
   PubMed Web of Science ®Google Scholar
• Swets JA. Measuring the accuracy of diagnostic systems. Science. 1988;240(4857):1285–1293.
   PubMed Web of Science ®Google Scholar
• Fischer JE, Bachmann LM, Jaeschke R. A readers’ guide to the interpretation of diagnostic test properties: clinical example of sepsis. Intensive Care Med. 2003;29(7):1043–1051.
   PubMed Web of Science ®Google Scholar
• Simundic AM. Measures of diagnostic accuracy: basic definitions. EJIFCC. 2009;19(4):203–211.
   PubMedGoogle Scholar
• Linnet K, Bossuyt PM, Moons KG, et al. Quantifying the accuracy of a diagnostic test or marker. Clin Chem. 2012;58(9):1292–1301.
   PubMed Web of Science ®Google Scholar
• Schlattmann P. Statistics in diagnostic medicine. Clin Chem Lab Med. 2022;60(6):801–807.
   PubMed Web of Science ®Google Scholar
• Walter SD. Properties of the summary receiver operating characteristic (SROC) curve for diagnostic test data. Stat Med. 2002;21(9):1237–1256.
   PubMed Web of Science ®Google Scholar
• Black S, Kushner I, Samols D. C-reactive protein. J Biol Chem. 2004;279(47):48487–48490.
   PubMed Web of Science ®Google Scholar
• Sproston NR, Ashworth JJ. Role of C-reactive protein at sites of inflammation and infection. Front Immunol. 2018;9:754.
   PubMed Web of Science ®Google Scholar
• Allin KH, Nordestgaard BG. Elevated C-reactive protein in the diagnosis, prognosis, and cause of cancer. Crit Rev Clin Lab Sci. 2011;48(4):155–170.
   PubMed Web of Science ®Google Scholar
• Zimmermann O, Li K, Zaczkiewicz M, et al. C-reactive protein in human atherogenesis: facts and fiction. Mediators Inflamm. 2014;2014:561428.
   PubMed Web of Science ®Google Scholar
• Enocsson H, Karlsson J, Li HY, et al. The complex role of C-reactive protein in systemic lupus erythematosus. JCM. 2021;10(24):5837.
   Google Scholar
• Ebell MH, Bentivegna M, Cai X, et al. Accuracy of biomarkers for the diagnosis of adult community-acquired pneumonia: a meta-analysis. Acad Emerg Med. 2020;27(3):195–206.
   PubMed Web of Science ®Google Scholar
• Kim JW, Yang IA, Oh EA, et al. C-reactive protein, sialic acid and adenosine deaminase levels in serum and pleural fluid from patients with pleural effusion. Korean J Intern Med. 1988;3(2):122–127.
   PubMedGoogle Scholar
• Porcel JM, Vives M, Cao G, et al. Biomarkers of infection for the differential diagnosis of pleural effusions. Eur Respir J. 2009;34(6):1383–1389.
   PubMed Web of Science ®Google Scholar
• Porcel JM, Bielsa S, Esquerda A, et al. Pleural fluid C-reactive protein contributes to the diagnosis and assessment of severity of parapneumonic effusions. Eur J Intern Med. 2012;23(5):447–450.
   PubMed Web of Science ®Google Scholar
• San Jose ME, Valdes L, Vizcaino LH, et al. Procalcitonin, C-reactive protein, and cell counts in the diagnosis of parapneumonic pleural effusions. J Investig Med. 2010;58(8):971–976.
   PubMed Web of Science ®Google Scholar
• Zou MX, Zhou RR, Wu WJ, et al. The use of pleural fluid procalcitonin and C-reactive protein in the diagnosis of parapneumonic pleural effusions: a systemic review and meta-analysis. Am J Emerg Med. 2012;30(9):1907–1914.
   PubMed Web of Science ®Google Scholar
• Li D, Shen Y, Qin J, et al. Diagnostic performance of C-reactive protein for parapneumonic pleural effusion: a meta-analysis. Ann Transl Med. 2019;7(1):1.
   PubMed Web of Science ®Google Scholar
• Skouras V, Boultadakis E, Nikoulis D, et al. Prognostic value of C-reactive protein in parapneumonic effusions. Respirology. 2012;17(2):308–314.
   PubMed Web of Science ®Google Scholar
• Porcel JM, Galindo C, Esquerda A, et al. Pleural fluid interleukin-8 and C-reactive protein for discriminating complicated non-purulent from uncomplicated parapneumonic effusions. Respirology. 2008;13(1):58–62.
   PubMed Web of Science ®Google Scholar
• Bielsa S, Valencia H, Ruiz-Gonzalez A, et al. Serum C-reactive protein as an adjunct for identifying complicated parapneumonic effusions. Lung. 2014;192(4):577–581.
   PubMed Web of Science ®Google Scholar
• Kogan Y, Sabo E, Odeh M. Diagnostic value of C-reactive protein in discrimination between uncomplicated and complicated parapneumonic effusion. Diagnostics. 2020;10(10):829.
   Web of Science ®Google Scholar
• Hooper C, Lee YC, Maskell N, BTS Pleural Guideline Group Investigation of a unilateral pleural effusion in adults: British Thoracic Society pleural disease guideline 2010. Thorax. 2010;65(Suppl 2):ii4–17.
   PubMed Web of Science ®Google Scholar
• Colice GL, Curtis A, Deslauriers J, et al. Medical and surgical treatment of parapneumonic effusions: an evidence-based guideline. Chest. 2000;118(4):1158–1171.
   PubMed Web of Science ®Google Scholar
• Heffner JE, Brown LK, Barbieri C, et al. Pleural fluid chemical analysis in parapneumonic effusions. A meta-analysis. Am J Respir Crit Care Med. 1995;151(6):1700–1708.
   PubMed Web of Science ®Google Scholar
• Lapworth R, Tarn AC, BritishThoracic S, Clinical Scince Reviews Committee of the Association for Clinical Biochemistry, et al. Commentary on the British Thoracic Society guidelines for the investigation of unilateral pleural effusion in adults. Ann Clin Biochem. 2006;43(Pt 1):17–22.
   PubMedGoogle Scholar
• Putnam B, Elahi A, Bowling MR. Do we measure pleural fluid pH correctly? Curr Opin Pulm Med. 2013;19(4):357–361.
   PubMed Web of Science ®Google Scholar
• Porcel JM, Valencia H, Bielsa S. Factors influencing pleural drainage in parapneumonic effusions. Rev Clin Esp. 2016;216(7):361–366.
   PubMed Web of Science ®Google Scholar
• Chen SC, Chen W, Hsu WH, et al. Role of pleural fluid C-reactive protein concentration in discriminating uncomplicated parapneumonic pleural effusions from complicated parapneumonic effusion and empyema. Lung. 2006;184(3):141–145.
   PubMed Web of Science ®Google Scholar
• Aloisio E, Dolci A, Panteghini M. Procalcitonin: between evidence and critical issues. Clin Chim Acta. 2019;496:7–12.
   PubMed Web of Science ®Google Scholar
• Davies J. Procalcitonin. J Clin Pathol. 2015;68(9):675–679.
   PubMed Web of Science ®Google Scholar
• Samsudin I, Vasikaran SD. Clinical utility and measurement of procalcitonin. Clin Biochem Rev. 2017;38(2):59–68.
   PubMedGoogle Scholar
• Schuetz P, Albrich W, Mueller B. Procalcitonin for diagnosis of infection and guide to antibiotic decisions: past, present and future. BMC Med. 2011;9:107.
   PubMed Web of Science ®Google Scholar
• Wei TT, Hu ZD, Qin BD, et al. Diagnostic accuracy of procalcitonin in bacterial meningitis versus nonbacterial meningitis: a systematic review and meta-analysis. Medicine. 2016;95(11):e3079.
   PubMed Web of Science ®Google Scholar
• Kamat IS, Ramachandran V, Eswaran H, et al. Procalcitonin to distinguish viral from bacterial pneumonia: a systematic review and meta-analysis. Clin Infect Dis. 2020;70(3):538–542.
   PubMed Web of Science ®Google Scholar
• Lin MC, Chen YC, Wu JT, et al. Diagnostic and prognostic values of pleural fluid procalcitonin in parapneumonic pleural effusions. Chest. 2009;136(1):205–211.
   PubMed Web of Science ®Google Scholar
• Dixon G, Lama-Lopez A, Bintcliffe OJ, et al. The role of serum procalcitonin in establishing the diagnosis and prognosis of pleural infection. Respir Res. 2017;18(1):30.
   PubMedGoogle Scholar
• He C, Wang B, Li D, et al. Performance of procalcitonin in diagnosing parapneumonic pleural effusions: a clinical study and meta-analysis. Medicine (Baltimore). 2017;96(33):e7829.
   PubMed Web of Science ®Google Scholar
• Watanabe N, Ishii T, Kita N, et al. The usefulness of pleural fluid presepsin, C-reactive protein, and procalcitonin in distinguishing different causes of pleural effusions. BMC Pulm Med. 2018;18(1):176.
   PubMed Web of Science ®Google Scholar
• Sharma A, Agrawal A, Sindhwani G, et al. Efficacy of procalcitonin and pentraxin-3 as early biomarkers for differential diagnosis of pleural effusions. Pleura Peritoneum. 2021;6(2):83–90.
   PubMed Web of Science ®Google Scholar
• Qu SY, Zhang Y, Wu S, et al. Combined analysis of C-reactive protein in pleural fluid and serum is effective in the differential diagnosis of exudative pleural effusions. Ann Transl Med. 2021;9(14):1183.
   PubMed Web of Science ®Google Scholar
• Wang CY, Hsiao YC, Jerng JS, et al. Diagnostic value of procalcitonin in pleural effusions. Eur J Clin Microbiol Infect Dis. 2011;30(3):313–318.
   PubMed Web of Science ®Google Scholar
• McCann FJ, Chapman SJ, Yu WC, et al. Ability of procalcitonin to discriminate infection from non-infective inflammation using two pleural disease settings. PLOS One. 2012;7(12):e49894.
   PubMed Web of Science ®Google Scholar
• Determann RM, Achouiti AA, El Solh AA, et al. Infectious pleural effusions can be identified by sTREM-1 levels. Respir Med. 2010;104(2):310–315.
   PubMed Web of Science ®Google Scholar
• Lee SH, Lee EJ, Min KH, et al. Procalcitonin as a diagnostic marker in differentiating parapneumonic effusion from tuberculous pleurisy or malignant effusion. Clin Biochem. 2013;46(15):1484–1488.
   PubMed Web of Science ®Google Scholar
• Yeo CD, Kim JW, Cho MR, et al. Pleural fluid pentraxin-3 for the differential diagnosis of pleural effusions. Tuberc Respir Dis (Seoul). 2013;75(6):244–249.
   PubMedGoogle Scholar
• Bouchon A, Dietrich J, Colonna M. Cutting edge: inflammatory responses can be triggered by TREM-1, a novel receptor expressed on neutrophils and monocytes. J Immunol. 2000;164(10):4991–4995.
   PubMed Web of Science ®Google Scholar
• Summah H, Tao LL, Zhu YG, et al. Pleural fluid soluble triggering receptor expressed on myeloid cells-1 as a marker of bacterial infection: a meta-analysis. BMC Infect Dis. 2011;11:280.
   PubMed Web of Science ®Google Scholar
• Gibot S, Cravoisy A, Levy B, et al. Soluble triggering receptor expressed on myeloid cells and the diagnosis of pneumonia. N Engl J Med. 2004;350(5):451–458.
   PubMed Web of Science ®Google Scholar
• Cao C, Gu J, Zhang J. Soluble triggering receptor expressed on myeloid cell-1 (sTREM-1): a potential biomarker for the diagnosis of infectious diseases. Front Med. 2017;11(2):169–177.
   PubMed Web of Science ®Google Scholar
• Liu CL, Hsieh WY, Wu CL, et al. Triggering receptor expressed on myeloid cells-1 in pleural effusions: a marker of inflammatory disease. Respir Med. 2007;101(5):903–909.
   PubMed Web of Science ®Google Scholar
• Chan MC, Chang KM, Chao WC, et al. Evaluation of a new inflammatory molecule (triggering receptor expressed on myeloid cells-1) in the diagnosis of pleural effusion. Respirology. 2007;12(3):333–338.
   PubMed Web of Science ®Google Scholar
• Bishara J, Goldberg E, Ashkenazi S, et al. Soluble triggering receptor expressed on myeloid cells-1 for diagnosing empyema. Ann Thorac Surg. 2009;87(1):251–254.
   PubMed Web of Science ®Google Scholar
• Schumann RR, Zweigner J. A novel acute-phase marker: lipopolysaccharide binding protein (LBP). Clin Chem Lab Med. 1999;37(3):271–274.
   PubMed Web of Science ®Google Scholar
• Vaure C, Liu Y. A comparative review of toll-like receptor 4 expression and functionality in different animal species. Front Immunol. 2014;5:316.
   PubMed Web of Science ®Google Scholar
• Zhang J, Hu ZD, Song J, et al. Diagnostic value of presepsin for sepsis: a systematic review and meta-analysis. Medicine (Baltimore). 2015;94(47):e2158.
   PubMed Web of Science ®Google Scholar
• Qi ZJ, Yu H, Zhang J, et al. Presepsin as a novel diagnostic biomarker for differentiating active pulmonary tuberculosis from bacterial community acquired pneumonia. Clin Chim Acta. 2018;478:152–156.
   PubMed Web of Science ®Google Scholar
• Chen KF, Chaou CH, Jiang JY, et al. Diagnostic accuracy of lipopolysaccharide-binding protein as biomarker for sepsis in adult patients: a systematic review and meta-analysis. PLOS One. 2016;11(4):e0153188.
   PubMed Web of Science ®Google Scholar
• Idell S. The pathogenesis of pleural space loculation and fibrosis. Curr Opin Pulm Med. 2008;14(4):310–315.
   PubMed Web of Science ®Google Scholar
• Komissarov AA, Rahman N, Lee YCG, et al. Fibrin turnover and pleural organization: bench to bedside. Am J Physiol Lung Cell Mol Physiol. 2018;314(5):L757–L768.
   PubMed Web of Science ®Google Scholar
• Higazi A, Cohen RL, Henkin J, et al. Enhancement of the enzymatic activity of single-chain urokinase plasminogen activator by soluble urokinase receptor. J Biol Chem. 1995;270(29):17375–17380.
   PubMed Web of Science ®Google Scholar
• Bakker OG, Hemmes SN, Backes Y, et al. SuPAR in pleural fluid may function as a biological marker for infection in critically ill patients with pleural effusions. J Infect. 2014;68(6):607–609.
   PubMed Web of Science ®Google Scholar
• Matzkies LM, Raggam RB, Flick H, et al. Prognostic and diagnostic potential of suPAR levels in pleural effusion. J Infect. 2017;75(5):465–467.
   PubMed Web of Science ®Google Scholar
• Ozsu S, Oztuna F, Mentese A, et al. Diagnostic value of suPAR in differentiating noncardiac pleural effusions from cardiac pleural effusions. Clin Respir J. 2016;10(1):61–66.
   PubMed Web of Science ®Google Scholar
• Arnold DT, Hamilton FW, Elvers KT, et al. Pleural fluid suPAR levels predict the need for invasive management in parapneumonic effusions. Am J Respir Crit Care Med. 2020;201(12):1545–1553.
   PubMed Web of Science ®Google Scholar
• Idell S, Lee YCG. suPAR surprises as a biomarker of invasive outcomes in pleural infection. Am J Respir Crit Care Med. 2020;201(12):1470–1472.
   PubMed Web of Science ®Google Scholar
• He X, Han B, Liu M. Long pentraxin 3 in pulmonary infection and acute lung injury. Am J Physiol Lung Cell Mol Physiol. 2007;292(5):L1039–1049.
   PubMed Web of Science ®Google Scholar
• Liu S, Qu X, Liu F, et al. Pentraxin 3 as a prognostic biomarker in patients with systemic inflammation or infection. Mediators Inflamm. 2014;2014:421429.
   PubMed Web of Science ®Google Scholar
• Bottazzi B, Bastone A, Doni A, et al. The long pentraxin PTX3 as a link among innate immunity, inflammation, and female fertility. J Leukoc Biol. 2006;79(5):909–912.
   PubMed Web of Science ®Google Scholar
• Staubli SM, Schäfer J, Rosenthal R, et al. The role of CRP and pentraxin 3 in the prediction of systemic inflammatory response syndrome and death in acute pancreatitis. Sci Rep. 2019;9(1):18340.
   PubMedGoogle Scholar
• Kunes P, Holubcova Z, Kolackova M, et al. Pentraxin 3(PTX 3): an endogenous modulator of the inflammatory response. Mediators Inflamm. 2012;2012:920517.
   PubMed Web of Science ®Google Scholar
• Ozsu S, Abul Y, Mentese A, et al. Pentraxin-3: a novel biomarker for discriminating parapneumonic from other exudative effusions. Respirology. 2013;18(4):657–662.
   PubMed Web of Science ®Google Scholar
• Çiftci F, Bilgin G, Özcan AN, et al. The diagnostic role of pentraxin-3 in the differential diagnosis of pleural effusions. Turk J Med Sci. 2018;48(6):1167–1174.
   PubMed Web of Science ®Google Scholar
• Dongel I, Gokmen AA, Camas HE, et al. Diagnostic significance of biochemical markers and pentraxin-3 in the differential diagnosis of malign, benign pleural effusion and empyema. J Pak Med Assoc. 2020;70(5):860–864.
   PubMed Web of Science ®Google Scholar
• Remick DG. Interleukin-8. Crit Care Med. 2005;33(12 Suppl):S466–S467.
   PubMedGoogle Scholar
• Harada A, Sekido N, Akahoshi T, et al. Essential involvement of interleukin-8 (IL-8) in acute inflammation. J Leukoc Biol. 1994;56(5):559–564.
   PubMed Web of Science ®Google Scholar
• Baggiolini M, Clark-Lewis I. Interleukin-8, a chemotactic and inflammatory cytokine. FEBS Lett. 1992;307(1):97–101.
   PubMed Web of Science ®Google Scholar
• Waugh DJ, Wilson C. The interleukin-8 pathway in cancer. Clin Cancer Res. 2008;14(21):6735–6741.
   PubMed Web of Science ®Google Scholar
• Broaddus VC, Hebert CA, Vitangcol RV, et al. Interleukin-8 is a major neutrophil chemotactic factor in pleural liquid of patients with empyema. Am Rev Respir Dis. 1992;146(4):825–830.
   PubMedGoogle Scholar
• Ashitani J, Mukae H, Nakazato M, et al. Elevated pleural fluid levels of defensins in patients with empyema. Chest. 1998;113(3):788–794.
   PubMed Web of Science ®Google Scholar
• Yokoyama A, Kohno N, Ito M, et al. Eotaxin levels in pleural effusions: comparison with monocyte chemoattractant protein-1 and IL-8. Intern Med. 2000;39(7):547–552.
   PubMed Web of Science ®Google Scholar
• Ceyhan BB, Ozgun S, Celikel T, et al. IL-8 in pleural effusion. Respir Med. 1996;90(4):215–221.
   PubMed Web of Science ®Google Scholar
• Yamada Y, Nakamura A, Hosoda M, et al. Cytokines in pleural liquid for diagnosis of tuberculous pleurisy. Respir Med. 2001;95(7):577–581.
   PubMed Web of Science ®Google Scholar
• Dlugovitzky D, Rateni L, Torres-Morales A, et al. Levels of interleukin-8 in tuberculous pleurisy and the profile of immunocompetent cells in pleural and peripheral compartments. Immunol Lett. 1997;55(1):35–39.
   PubMed Web of Science ®Google Scholar
• San Jose ME, Ferreiro L, Soneira ME, et al. Utility of measurement of interleukin-1ss and interleukin-8 in the diagnosis of complicated parapneumonic pleural effusions. Am J Clin Pathol. 2014;142(4):467–473.
   PubMed Web of Science ®Google Scholar
• Chung CL, Hsiao SH, Hsiao G, et al. Clinical importance of angiogenic cytokines, fibrinolytic activity and effusion size in parapneumonic effusions. PLOS One. 2013;8(1):e53169.
   PubMed Web of Science ®Google Scholar
• Saraya T, Ohkuma K, Watanabe T, et al. Diagnostic value of vascular endothelial growth factor, transforming growth factor-β, interleukin-8, and the ratio of lactate dehydrogenase to adenosine deaminase in pleural effusion. Lung. 2018;196(2):249–254.
   PubMed Web of Science ®Google Scholar
• Iglesias D, Alegre J, Aleman C, et al. Metalloproteinases and tissue inhibitors of metalloproteinases in exudative pleural effusions. Eur Respir J. 2005;25(1):104–109.
   PubMed Web of Science ®Google Scholar
• Utine GE, Ozcelik U, Yalcin E, et al. Childhood parapneumonic effusions: biochemical and inflammatory markers. Chest. 2005;128(3):1436–1441.
   PubMed Web of Science ®Google Scholar
• Petrusevska Marinkovic S, Kondova Topuzovska I, Milenkovic Z, et al. Role of interleukin-8 in differentiation of uncomplicated from complicated parapneumonic effusion. Prilozi. 2011;32(1):101–111.
   PubMedGoogle Scholar
• Gabay C, Kushner I. Acute-phase proteins and other systemic responses to inflammation. N Engl J Med. 1999;340(6):448–454.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Zhang J, Sheng H, et al. Acute phase reactant serum amyloid a in inflammation and other diseases. Adv Clin Chem. 2019;90:25–80.
   PubMed Web of Science ®Google Scholar
• Okino AM, Burger C, Cardoso JR, et al. The acute-phase proteins serum amyloid A and C reactive protein in transudates and exudates. Mediators Inflamm. 2006;2006(1):47297.
   PubMedGoogle Scholar
• Boultadakis V, Skouras V, Makris D, et al. Serum amyloid alpha in parapneumonic effusions. Mediators Inflamm. 2011;2011:237638.
   PubMed Web of Science ®Google Scholar
• Kumar H, Kawai T, Akira S. Pathogen recognition by the innate immune system. Int Rev Immunol. 2011;30(1):16–34.
   PubMed Web of Science ®Google Scholar
• Akira S, Uematsu S, Takeuchi O. Pathogen recognition and innate immunity. Cell. 2006;124(4):783–801.
   PubMed Web of Science ®Google Scholar
• Yokoyama A, Maruyama M, Ito M, et al. Interleukin 6 activity in pleural effusion. Its diagnostic value and thrombopoietic activity. Chest. 1992;102(4):1055–1059.
   PubMed Web of Science ®Google Scholar
• Xirouchaki N, Tzanakis N, Bouros D, et al. Diagnostic value of interleukin-1alpha, interleukin-6, and tumor necrosis factor in pleural effusions. Chest. 2002;121(3):815–820.
   PubMed Web of Science ®Google Scholar
• San Jose ME, Valdes L, Gonzalez-Barcala FJ, et al. Diagnostic value of proinflammatory interleukins in parapneumonic effusions. Am J Clin Pathol. 2010;133(6):884–891.
   PubMed Web of Science ®Google Scholar
• Daniil ZD, Zintzaras E, Kiropoulos T, et al. Discrimination of exudative pleural effusions based on multiple biological parameters. Eur Respir J. 2007;30(5):957–964.
   PubMed Web of Science ®Google Scholar
• Kiropoulos TS, Kostikas K, Oikonomidi S, et al. Acute phase markers for the differentiation of infectious and malignant pleural effusions. Respir Med. 2007;101(5):910–918.
   PubMed Web of Science ®Google Scholar
• Ilonidis G, Parapanisiou E, Anogeianaki A, et al. Interleukin -1beta (IL-1 beta), interleukin 6 (IL-6) and tumor necrosis factor (TNF) in plasma and pleural fluid of pneumonia, lung cancer and tuberculous pleuritis. J Biol Regul Homeost Agents. 2006;20(1-2):41–46.
   PubMed Web of Science ®Google Scholar
• Ferreiro L, Lado-Baleato O, Suarez-Antelo J, et al. Diagnosis of infectious pleural effusion using predictive models based on pleural fluid biomarkers. Ann Thorac Med. 2019;14(4):254–263.
   PubMed Web of Science ®Google Scholar
• Lin FC, Chen YC, Chen FJ, et al. Cytokines and fibrinolytic enzymes in tuberculous and parapneumonic effusions. Clin Immunol. 2005;116(2):166–173.
   PubMed Web of Science ®Google Scholar
• Akarsu S, Kurt AN, Dogan Y, et al. The differential diagnostic values of cytokine levels in pleural effusions. Mediators Inflamm. 2005;2005(1):2–8.
   PubMedGoogle Scholar
• Momi H, Matsuyama W, Inoue K, et al. Vascular endothelial growth factor and proinflammatory cytokines in pleural effusions. Respir Med. 2002;96(10):817–822.
   PubMed Web of Science ®Google Scholar
• Klimiuk J, Krenke R, Safianowska A, et al. Diagnostic performance of different pleural fluid biomarkers in tuberculous pleurisy. Adv Exp Med Biol. 2015;852:21–30.
   PubMed Web of Science ®Google Scholar
• Zhang M, Li D, Hu ZD, et al. The diagnostic utility of pleural markers for tuberculosis pleural effusion. Ann Transl Med. 2020;8(9):607.
   PubMed Web of Science ®Google Scholar
• Aggarwal AN, Agarwal R, Dhooria S, et al. Pleural fluid tumor necrosis factor for diagnosis of pleural tuberculosis: a systematic review and meta-analysis. Cytokine. 2021;141:155467.
   PubMed Web of Science ®Google Scholar
• Odeh M, Makhoul B, Sabo E, et al. The role of pleural fluid-serum gradient of tumor necrosis factor-alpha concentration in discrimination between complicated and uncomplicated parapneumonic effusion. Lung. 2005;183(1):13–27.
   PubMed Web of Science ®Google Scholar
• Porcel JM, Vives M, Esquerda A. Tumor necrosis factor-alpha in pleural fluid: a marker of complicated parapneumonic effusions. Chest. 2004;125(1):160–164.
   PubMed Web of Science ®Google Scholar
• Odeh M, Sabo E, Srugo I, et al. Correlation between polymorphonuclear leukocyte counts and levels of tumor necrosis factor-a in pleural fluid of patients with parapneumonic effusion. Lung. 2002;180(5):265–271.
   PubMed Web of Science ®Google Scholar
• Odeh M, Sabo E, Oliven A, et al. Role of tumor necrosis factor-alpha in the differential diagnosis of parapneumonic effusion. Int J Infect Dis. 2000;4(1):38–41.
   PubMedGoogle Scholar
• Chiu CY, Wong KS, Huang JL, et al. Proinflammatory cytokines, fibrinolytic system enzymes, and biochemical indices in children with infectious para-pneumonic effusions. Pediatr Infect Dis J. 2008;27(8):699–703.
   PubMed Web of Science ®Google Scholar
• Ciledag A, Kaya A, Erol S, et al. The comparison of pleural fluid TNF-alpha and IL-10 levels with ADA in tuberculous pleural effusion. Curr Med Chem. 2010;17(19):2096–2100.
   PubMed Web of Science ®Google Scholar
• Zaga T, Makris D, Tsilioni I, et al. Hyaluronic acid levels are increased in complicated parapneumonic pleural effusions. Monaldi Arch Chest Dis. 2011;75(3):167–171.
   PubMedGoogle Scholar
• Vu TH, Werb Z. Matrix metalloproteinases: effectors of development and normal physiology. Genes Dev. 2000;14(17):2123–2133.
   PubMed Web of Science ®Google Scholar
• Cui N, Hu M, Khalil RA. Biochemical and biological attributes of matrix metalloproteinases. Prog Mol Biol Transl Sci. 2017;147:1–73.
   PubMed Web of Science ®Google Scholar
• Jantz MA, Antony VB. Pathophysiology of the pleura. Respiration. 2008;75(2):121–133.
   PubMed Web of Science ®Google Scholar
• Zhang M, Yan L, Lippi G, et al. Pleural biomarkers in diagnostics of malignant pleural effusion: a narrative review. Transl Lung Cancer Res. 2021;10(3):1557–1570.
   PubMed Web of Science ®Google Scholar
• Kremer R, Best LA, Savulescu D, et al. Pleural fluid analysis of lung cancer vs benign inflammatory disease patients. Br J Cancer. 2010;102(7):1180–1184.
   PubMed Web of Science ®Google Scholar
• Sundararajan S, Babu S, Das SD. Comparison of localized versus systemic levels of matrix metalloproteinases (MMPs), its tissue inhibitors (TIMPs) and cytokines in tuberculous and non-tuberculous pleuritis patients. Hum Immunol. 2012;73(10):985–991.
   PubMed Web of Science ®Google Scholar
• Oikonomidi S, Kostikas K, Kalomenidis I, et al. Matrix metalloproteinase levels in the differentiation of parapneumonic pleural effusions. Respiration. 2010;80(4):285–291.
   PubMed Web of Science ®Google Scholar
• Fiorelli A, Morgillo F, Fasano M, et al. The value of matrix metalloproteinase-9 and vascular endothelial growth factor receptor 1 pathway in diagnosing indeterminate pleural effusion. Interact Cardiovasc Thorac Surg. 2013;16(3):263–269.
   PubMed Web of Science ®Google Scholar
• Teixeira LR, Dias MB, Sales RK, et al. Profile of metalloproteinases and their association with inflammatory markers in pleural effusions. Lung. 2016;194(6):1021–1027.
   PubMed Web of Science ®Google Scholar
• Vatansever S, Gelisgen R, Uzun H, et al. Potential role of matrix metalloproteinase-2,-9 and tissue inhibitors of metalloproteinase-1,-2 in exudative pleural effusions. Clin Invest Med. 2009;32(4):E293–300.
   PubMedGoogle Scholar
• Sheen P, O'Kane CM, Chaudhary K, et al. High MMP-9 activity characterises pleural tuberculosis correlating with granuloma formation. Eur Respir J. 2009;33(1):134–141.
   PubMed Web of Science ®Google Scholar
• Stewart CM, Kothari PD, Mouliere F, et al. The value of cell-free DNA for molecular pathology. J Pathol. 2018;244(5):616–627.
   PubMed Web of Science ®Google Scholar
• Chan MH, Chow KM, Chan AT, et al. Quantitative analysis of pleural fluid cell-free DNA as a tool for the classification of pleural effusions. Clin Chem. 2003;49(5):740–745.
   PubMed Web of Science ®Google Scholar
• Santotoribio JD, Cabrera-Alarcon JL, Batalha-Caetano P, et al. Pleural fluid cell-free DNA in parapneumonic pleural effusion. Clin Biochem. 2015;48(15):1003–1005.
   PubMed Web of Science ®Google Scholar
• Su CM, Kung CT, Hsiao SY, et al. Diagnosis of parapneumonia pleural effusion with serum and pleural fluid cell-free DNA. Biomed Res Int. 2019;2019:5028512.
   PubMed Web of Science ®Google Scholar
• Zhao W, Cao XS, Han YL, et al. Diagnostic utility of pleural cell-free nucleic acids in undiagnosed pleural effusions. Clin Chem Lab Med. 2022;60(10):1518–1524.
   PubMed Web of Science ®Google Scholar
• Wu KA, Wu CC, Chen CD, et al. Proteome profiling reveals novel biomarkers to identify complicated parapneumonic effusions. Sci Rep. 2017;7(1):4026.
   PubMedGoogle Scholar
• Wu KA, Wu CC, Liu YC, et al. Combined serum biomarkers in the noninvasive diagnosis of complicated parapneumonic effusions and empyema. BMC Pulm Med. 2019;19(1):108.
   PubMedGoogle Scholar
• Gümüs A, Ozkaya S, Ozyurt S, et al. A novel biomarker in the diagnosis of parapneumonic effusion: neutrophil gelatinase-associated lipocalin. Multidiscip Respir Med. 2014;9(1):49.
   PubMedGoogle Scholar
• Sanchez-Otero N, Blanco-Prieto S, Paez de la Cadena M, et al. Calprotectin: a novel biomarker for the diagnosis of pleural effusion. Br J Cancer. 2012;107(11):1876–1882.
   PubMed Web of Science ®Google Scholar
• Botana-Rial M, Vazquez-Iglesias L, Casado-Rey P, et al. Validation of calprotectin as a novel biomarker for the diagnosis of pleural effusion: a multicentre trial. Sci Rep. 2020;10(1):5679.
   PubMed Web of Science ®Google Scholar
• Casado-Rey P, Vazquez-Iglesias L, Botana-Rial M, et al. A rapid calprotectin test for the diagnosis of pleural effusion. PLOS One. 2021;16(6):e0252714.
   PubMed Web of Science ®Google Scholar
• Saberi-Karimian M, Khorasanchi Z, Ghazizadeh H, et al. Potential value and impact of data mining and machine learning in clinical diagnostics. Crit Rev Clin Lab Sci. 2021;58:275–296.
   PubMed Web of Science ®Google Scholar
• Ren Z, Hu Y, Xu L. Identifying tuberculous pleural effusion using artificial intelligence machine learning algorithms. Respir Res. 2019;20(1):220.
   PubMed Web of Science ®Google Scholar
• Garcia-Zamalloa A, Vicente D, Arnay R, with the Gipuzkoa Pleura Group Consortium, et al. Diagnostic accuracy of adenosine deaminase for pleural tuberculosis in a low prevalence setting: a machine learning approach within a 7-year prospective multi-center study. PLOS One. 2021;16(11):e0259203.
   PubMed Web of Science ®Google Scholar
• Hayashi Y, Shimada T, Hattori N, et al. A prehospital diagnostic algorithm for strokes using machine learning: a prospective observational study. Sci Rep. 2021;11(1):20519.
   PubMed Web of Science ®Google Scholar
• Yang C, Zhou S, Zhu J, et al. Plasma lipid-based machine learning models provides a potential diagnostic tool for colorectal cancer patients. Clin Chim Acta. 2022;536:191–199.
   PubMed Web of Science ®Google Scholar
• Wang S, Wang Q, Fan B, et al. Machine learning-based screening of the diagnostic genes and their relationship with immune-cell infiltration in patients with lung adenocarcinoma. J Thorac Dis. 2022;14(3):699–711.
   PubMed Web of Science ®Google Scholar
• Ren M, Li L, Chu M, et al. Detection of Klebsiella pneumoniae cfDNA in pleural fluid and its clinical value. Ann Palliat Med. 2020;9(5):3379–3384.
   PubMed Web of Science ®Google Scholar
• Franchetti L, Schumann DM, Tamm M, et al. Multiplex bacterial polymerase chain reaction in a cohort of patients with pleural effusion. BMC Infect Dis. 2020;20(1):99.
   PubMed Web of Science ®Google Scholar
• Pernica JM, Moldovan I, Chan F, et al. Real-time polymerase chain reaction for microbiological diagnosis of parapneumonic effusions in Canadian children. Can J Infect Dis Med Microbiol. 2014;25(3):151–154.
   PubMed Web of Science ®Google Scholar
• Lampejo T, Ciesielczuk H, Lambourne J. Clinical utility of 16S rRNA PCR in pleural infection. J Med Microbiol. 2021;70(5):001366.
   PubMed Web of Science ®Google Scholar
• Shiraishi Y, Kryukov K, Tomomatsu K, et al. Diagnosis of pleural empyema/parapneumonic effusion by next-generation sequencing. Infect Dis. 2021 Jun;53(6):450–459.
   PubMed Web of Science ®Google Scholar